MedPath

M-METRONIDAZOLE

M-METRONIDAZOLE

Approved
DIN Number

02519755

Drug Class

Human

Market Date

Mar 4, 2022

Company
HC

mantra pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02519755
AIG Number0102572003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01AB01 METRONIDAZOLE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:30.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

METRONIDAZOLEActive
Strength: 500 MG
Monograph: METRONIDAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.